Duloxetine/pregabalin - Eurofarma
Alternative Names: N-0750Latest Information Update: 30 Dec 2024
Price :
$50 *
At a glance
- Originator Eurofarma
- Class Non-opioid analgesics
- Mechanism of Action Adrenergic uptake inhibitors; CACNA2D1 protein modulators; Serotonin plasma membrane transport protein inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neuropathic pain
Most Recent Events
- 04 Dec 2024 Preclinical trials in Neuropathic pain in Brazil (PO)
- 04 Dec 2024 Eurofarma plans the phase-III ENFORCE trial for Neuropathic pain in Brazil in November 2025 (PO), (NCT06715462),